Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists

SHANGHAI, China, March 31 /Xinhua-PRNewswire/ -- WuXi PharmaTech, the
leading pharmaceutical, biotechnology and medical device R&D outsourcing
company with operations in China and the United States, was very honored to
have Professor David W. C. MacMillan, a renowned researcher from Princeton
University, as a WuXi PharmaTech Science Seminar Series speaker who delivered
a lecture to the company's young scientists on March 25, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
Aiming to keep the company's young scientists abreast of the latest drug
R&D knowledge and technologies, the WuXi PharmaTech Science Seminar Series is
a monthly program that invites accomplished researchers from academia and the
industry to share their wealth of experience and expertise with the company's
scientists.
Dr. David MacMillan obtained his undergraduate degree from Glasgow
University, and in 1990 moved to the University of California, Irvine, where
he obtained his Ph.D. under the direction of Larry E. Overman. Following
postdoctoral research with David A. Evans at Harvard University, Dr. MacMillan
began his independent research career at the University of California,
Berkeley, in 1998. In 2000, he joined the department of chemistry at Caltech,
and was promoted to full professor in 2003. He was appointed to the A. Barton
Hepbum Chair of Chemistry and Director of the Merck Center for Catalysis at
Princeton University in June 2006.
Dr. MacMillan is a leader in the currently active area of asymmetric
organocatalysis. His numerous accomplishments have found widespread industrial
application and his success is evidenced by the numerous awards and honors he
has received from professional associations like the Royal Society of
Chemistry, the American Chemical Society and the industry.
"We are very honored and privileged to have Dr. MacMillan as one of our
seminar speakers. His remarkable achievements in the field of organic
synthesis will motivate our young scientists," said Dr. Shuhui Chen, Chief
Scientific Officer of the company. "As a research-driven company serving
global pharmaceutical, biotechnology and medical device companies, we believe
science has no boundary. We will continue inviting heavy-weight speakers to
WuXi so that our scientists can learn from the best, and ultimately provide
better services to our customers."
About WuXi PharmaTech
WuXi PharmaTech, headquartered in Shanghai, China, is a leading global
pharmaceutical, biotechnology and medical device R&D outsourcing company with
operations in China and the U.S. As a research-driven and customer-focused
company, WuXi PharmaTech provides a broad and integrated portfolio of
laboratory and manufacturing services throughout the drug and medical device
R&D process to pharmaceutical, biotechnology and medical device companies. Our
services are designed to assist our global customers in shortening the time
and lowering the cost of drug and medical device R&D by providing cost-
effective and efficient outsourcing solutions. For more information, please
visit: http://www.wuxipharmatech.com .
For more information, please contact:

Sherry Shao
Tel: +86-21-5046-4002
Email: pr@pharmatechs.com

SOURCE WuXi PharmaTech

Sherry Shao of WuXi PharmaTech, +86-21-5046-4002, or pr@pharmatechs.com